The Patient Just May Be Getting More Than Expected From the Drug Therapy.

Pradaxa is an anticoagulant, or blood thinner used to prevent the occurrence of stroke in heart patients suffering from atrial fibrillation, a serious heart condition. Patients suffering from this condition are at risk of blood clots. The medication thins the blood sufficiently to prevent  clotting of the blood, resulting in a disabling or life-threatening stroke. Pradaxa has proved to be an effective therapy in the patients who have used it. An alternative medication used in the same capacity is cumadin. Cumadin is cost-effective but has been found to have unpleasant side effects and is not always  well-tolerated by patients using it. Thus, Pradaxa has been a welcome alternative to Cumadin therapy in heart patients and other patients at risk of having a stroke.

Pradaxa has not been the total solution to avoiding Cumadin, however. Use of Pradaxa has been found to cause the dangerous condition of internal bleeding in patients using the medication. If left untreated, internal bleeding can cause health effects which can be life-threatening to patients. The life-threatening effects of Cumadin are merely not as acute and immediate as the effects of a stroke. Ceasing use of the Pradaxa will prevent further internal bleeding from starting, but the internal bleeding which has already started does not necessarily stop immediatelyl upon the cessation of the Pradaxa and  must be remedied another way.

Individuals whose health has been impacted by the use of Pradaxa in an attempt to prevent stroke should consider legal recourse to compensate them for their losses. Attorney David Grebel, St. Louis area personal injury attorney, has successfully pursued numerous successful cases alleging injury from the internal bleeding caused by use of Pradaxa in an attempt to prevent blood clots and stroke in heart patients and others in need of anticoagulant therapy.

This entry was posted in pradaxa. Bookmark the permalink.